Chong Lu - Publications

Repeated intravenous weight-based ustekinumab maintenance as an optimization strategy for Crohn's disease patients with loss of response to standard therapy.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 05, 2025

Predictive value of the Chinese Visceral Adiposity Index for disease activity and vedolizumab response in ulcerative colitis.

Journal: Nutricion hospitalaria

Published: September 29, 2025

Efficacy and safety of dual biologics or combination therapy with JAK inhibitors in refractory inflammatory bowel disease: a retrospective single-center real-world study from China.

Journal: BMC gastroenterology

Published: September 18, 2025

The immunomodulatory effects of intratumoral microbiota on tumor initiation, progression, and metastasis: From understanding to therapy.

Journal: Critical reviews in oncology/hematology

Published: August 05, 2025

Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysis.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: January 20, 2025

A Rare Case with Recurrent Abdominal Pain as the First Symptom: AL Amyloidosis with Colon Involvement Combined with Pulmonary Adenocarcinoma.

Journal: Journal of inflammation research

Published: July 27, 2024

An Unusual Cause of Intestinal Ulcers Masquerading as Inflammatory Bowel Disease: A Case Report of Allied Disorders of Hirschsprung's Disease.

Journal: Journal of inflammation research

Published: January 15, 2024

A High-Salt Diet Exacerbates Liver Fibrosis through Enterococcus-Dependent Macrophage Activation.

Journal: Microbiology spectrum

Published: February 14, 2023

A fatal outcome in a patient with coeliac disease who suspended a strict gluten-free diet: a case report.

Journal: The Journal of international medical research

Published: December 14, 2021

The efficacy and safety of adding bevacizumab in neoadjuvant therapy for locally advanced rectal cancer patients: A systematic review and meta-analysis.

Journal: Translational oncology

Published: July 28, 2020

The relationship between vitronectin and hepatic insulin resistance in type 2 diabetes mellitus.

Journal: Endocrine journal

Published: May 22, 2018

Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis.

Journal: Oncotarget

Published: July 18, 2017